<?xml version="1.0" encoding="UTF-8"?><Media xmlns:cdr="cips.nci.nih.gov/cdr" BlockedFromVOL="Yes">
 
 <MediaTitle>Childhood Cancer Genomics - ALL Figure</MediaTitle>
 <PhysicalMedia>
  <ImageData>
   <ImageType>chart</ImageType>
   <ImageEncoding>JPEG</ImageEncoding>
   <Color>Color</Color>
   <Labeled>Yes</Labeled>
   <LabelName language="en">ETV6-RUNX1</LabelName><LabelName language="en">22%</LabelName><LabelName language="en">Hyperdiploid</LabelName><LabelName language="en">20%</LabelName><LabelName language="en">MLL rearrangements</LabelName><LabelName language="en">6%</LabelName><LabelName language="en">TCF3-PBX1</LabelName><LabelName language="en">4%</LabelName><LabelName language="en">BCR-ABL1</LabelName><LabelName language="en">2%</LabelName><LabelName language="en">Dicentric</LabelName><LabelName language="en">3%</LabelName><LabelName language="en">Hypodiploid</LabelName><LabelName language="en">1%</LabelName><LabelName language="en">iAMP21</LabelName><LabelName language="en">1%</LabelName><LabelName language="en">CRLF2</LabelName><LabelName language="en">4%</LabelName><LabelName language="en">(CRLF2)</LabelName><LabelName language="en">3.5%</LabelName><LabelName language="en">BCR-ABL1-like</LabelName><LabelName language="en">9%</LabelName><LabelName language="en">(Other)</LabelName><LabelName language="en">5.5%</LabelName><LabelName language="en">ERG</LabelName><LabelName language="en">3%</LabelName><LabelName language="en">Others (B-ALL)</LabelName><LabelName language="en">10%</LabelName><LabelName language="en">TAL1</LabelName><LabelName language="en">7%</LabelName><LabelName language="en">TLX3</LabelName><LabelName language="en">2.3%</LabelName><LabelName language="en">ETP</LabelName><LabelName language="en">2%</LabelName><LabelName language="en">LYL1</LabelName><LabelName language="en">1.4%</LabelName><LabelName language="en">TLX1</LabelName><LabelName language="en">0.3%</LabelName><LabelName language="en">Others (T-ALL)</LabelName><LabelName language="en">2%</LabelName><ImageDimensions>
    <HeightPixels>362</HeightPixels>
    <WidthPixels>565</WidthPixels>
   </ImageDimensions>
  </ImageData>
 </PhysicalMedia>
 <MediaSource>
  <OriginalSource>
   <Creator>Seminars in Hematology</Creator>
   <SourcePublication>Mullighan CG, Genomic characterization of childhood acute lymphoblastic leukemia. Seminars in Hematology, Volume 50 (Issue 4),  Pages 314–324, Copyright 2013.</SourcePublication><DateCreated>2016-08-08</DateCreated>
   <SourceFilename>Mullighan image Ch Cancer Genomics 8-8-16  x2.jpg</SourceFilename>
  <Comment audience="Internal" date="2016-08-08" user="kuhlmanna">Figure approved by PDQ Pediatric Treatment  Editorial Board and permissions received - 08/08/16</Comment><Comment audience="Internal" date="2015-09-01" user="kuhlmanna">Permissions needed; image added as draft for summary placeholder - need Board approval</Comment></OriginalSource>
 </MediaSource>
 <PermissionInformation>
    <PermissionRequested>Yes</PermissionRequested>
    
    <PermissionResponse>Permission Granted</PermissionResponse>
    <PermissionResponseDate>2016-08-04</PermissionResponseDate>
    
    <PublisherPermissionText>Reprinted from Seminars in Hematology, Volume 50 (Issue 4), Charles G. Mullighan, Genomic Characterization of Childhood Acute Lymphoblastic Leukemia, Pages 314–324, Copyright (2013), with permission from Elsevier.</PublisherPermissionText>
    <ApprovedUse>
     <Summary cdr:ref="CDR0000774921">Childhood Cancer Genomics</Summary>
     
    </ApprovedUse>
    <SpanishTranslationPermissionRequested>Yes</SpanishTranslationPermissionRequested>
    
    <CitationLink cdr:ref="CDR0000775150">Genomic characterization of childhood acute lymphoblastic leukemia.</CitationLink><Comment audience="Internal" date="2016-08-08" user="kuhlmanna">Figure approved by PDQ Pediatric Treatment  Editorial Board and permissions received - 08/08/16</Comment></PermissionInformation><MediaContent>
  <Categories>
   <Category>genetics</Category>
  </Categories>
  <Diagnoses>
   <Diagnosis cdr:ref="CDR0000039919">childhood acute lymphoblastic leukemia</Diagnosis>
  </Diagnoses>
  
  <ContentDescriptions>
   <ContentDescription audience="Health_professionals" language="en">Pie chart showing subclassification of childhood ALL.</ContentDescription>
  </ContentDescriptions>
  <Captions>
   <MediaCaption audience="Health_professionals" language="en">Subclassification of childhood ALL. Blue wedges refer to B-progenitor ALL, yellow to recently identified subtypes of B-ALL, and red wedges to T-lineage ALL. Reprinted from Seminars in Hematology, Volume 50, Charles G. Mullighan, Genomic Characterization of Childhood Acute Lymphoblastic Leukemia, Pages 314–324, Copyright (2013), with permission from Elsevier.</MediaCaption>
  </Captions>
 </MediaContent>
 
 
<ProposedUse>
       <Summary cdr:ref="CDR0000062923">Childhood Acute Lymphoblastic Leukemia Treatment</Summary>
       </ProposedUse><ProcessingStatuses><ProcessingStatus>
        <ProcessingStatusValue>Ready for Publishing</ProcessingStatusValue>
        <ProcessingStatusDate>2016-08-08</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        
       </ProcessingStatus><ProcessingStatus>
        <ProcessingStatusValue>Copyright Permissions Received</ProcessingStatusValue>
        <ProcessingStatusDate>2016-08-05</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        
       </ProcessingStatus><ProcessingStatus>
        <ProcessingStatusValue>HP illustration approved</ProcessingStatusValue>
        <ProcessingStatusDate>2016-07-22</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        
       </ProcessingStatus>
       <ProcessingStatus>
        <ProcessingStatusValue>HP illustration pending</ProcessingStatusValue>
        <ProcessingStatusDate>2016-07-13</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        
       </ProcessingStatus></ProcessingStatuses><RelatedDocuments>
         <SupplementaryInfoLink cdr:ref="CDR0000782665">Mullighan_Figure_CopyrightPermissions_2016-08-05</SupplementaryInfoLink>
       </RelatedDocuments></Media>
